![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/kedrion-selected-by-biotest-to-distribute-its-immunoglobulin-yimmugo-in-the-us-following-recent-fda-approval-302186408.html
https://www.prnewswire.com/news-releases/kedrion-announces-rare-disease-medicine-ryplazim-now-available-in-us-302130342.html
https://www.prnewswire.com/news-releases/kedrion-announces-an-eight-year-extension-of-the-distribution-agreement-with-kamada-in-the-us-for-kedrab-302009137.html
https://www.prnewswire.com/news-releases/kedrion-biopharma-announces-support-for-the-immune-deficiency-foundation-research-grant-program-for-second-consecutive-year-301885635.html
https://www.prnewswire.com/news-releases/kedrions-global-portfolio-expands-to-china-to-supply-human-albumin-301875789.html
https://www.prnewswire.com/news-releases/kedrion-strengthens-its-network-of-plasma-collection-centers-301695652.html
https://www.prnewswire.com/news-releases/kedrion-biopharma-redeems-200m-of-its-notes-that-fall-due-in-2022-301536438.html
https://www.prnewswire.com/news-releases/kedrion-reports-a-15-ebitda-on-660-4m-of-revenues-in-2021--301522628.html
https://www.prnewswire.com/news-releases/lfb-and-kedrion-sign-an-industrial-cooperation-agreement-to-supply-immunoglobulins-to-meet-patient-demand-in-france-301470815.html
https://www.prnewswire.com/news-releases/kedrion-biopharma-to-commercialize-ryplazim-plasminogen-human-tvmh-in-us-to-address-unmet-need-in-patients-with-ultra-rare-condition-plasminogen-deficiency-type-1-301404273.html